bioAffinity Technologies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
bioAffinity Technologies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2021 to Q4 2023.
  • bioAffinity Technologies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $8.06M, a 59.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $8.06M +$3.01M +59.6% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $5.05M +$824K +19.5% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $4.23M Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.